Drug Discovery

#Drug development #Drug discovery #Obesity #RNA Therapeutics

New DDW Highlights podcast: 2 June 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. News stories of note for this week include a major deal signed between Eli… Read More

#News

#Artificial intelligence (AI) #Drug discovery #Events #Webinar

Webinar: The impact of AI on drug discovery innovation

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More

Webinar date:
Sponsored by Benchling
#News

Francis Crick Institute
#Drug discovery #Events #Turning Science into Business Symposium

Speakers announced for DDW Symposium

On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London. Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they… Read More

#Editor's Choice #News

RNA
#Drug development #Drug discovery #Obesity #RNA Therapeutics

This week in drug discovery (26-30 May)

News round-up for 26-30 May by DDW Editor Reece Armstrong. News stories of note for this week include a major deal signed between Eli Lilly and Rznomics in the field of RNA-editing therapies, and a potential quality-of-life breakthrough for patients with Parkinson’s. Lilly and Rznomics agree $1.3 billion… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer #Drug development #Drug discovery

Insilico Medicine study validates ENPP1 as immune checkpoint for cancers  

Biotechnology company Insilico Medicine has unveiled a new study showcasing how the company’s advanced generative AI platform and integrated workflow helped to identify and validate ENPP1 as a critical immune checkpoint among multiple solid tumours, which helped to the development of a highly specific oral ENPP1 inhibitor, ISM5939. Read More

#News

Biomarkers concept
#Biomarkers #Drug discovery #Endometriosis #Genetics / genomics #Neurodegenerative disorders #Neuroscience #Women's health

New podcast: Innovative uses for biomarkers in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “How biomarkers can help discover new treatments for women’s health” and… Read More

#News

#Drug discovery #SLAS Europe

SLAS Europe round-up 

DDW’s Reece Armstrong looks at the latest announcements that came out of SLAS Europe.   Contract research organisation (CRO) Nanoworx announced its nanomedicine development and optimisation services at this year’s SLAS Europe. The CRO’s new service is designed for academic and industry partners and is tailored to… Read More

#News

#App note #Biopharma #Drug development

New guide: Unlocking the biopharma development pipeline

A new Introductory Guide is now available for download entitled ‘Unlocking the biopharma development pipeline‘. Discover a new generation of molecular sensing technology from Oxford Nanopore Technologies that is transforming the biopharma development pipeline. You’ll explore: How Oxford Nanopore sequencing overcomes challenges faced in the drug development process Advantages… Read More

#News

#App note #Biopharma #Drug development

Unlocking the biopharma development pipeline

A new Introductory Guide is now available for download entitled ‘Unlocking the biopharma development pipeline‘. Discover a new generation of molecular sensing technology from Oxford Nanopore Technologies that is transforming the biopharma development pipeline. You’ll explore: How Oxford Nanopore sequencing overcomes challenges faced in the drug development process Advantages… Read More

#Resources

#Cancer research #Drug discovery #Events #Oncology #Webinar

Webinar: Innovation and development in cancer research

This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. … Read More

Webinar date:
Sponsored by Scale Biosciences
#News

#Drug discovery #Events #Neuroscience #Webinar

Webinar: Hear from the experts in neuroscience drug discovery

Hosted by Drug Discovery World and sponsored by Emulate, this free webinar explores where innovation is taking place within neuroscience drug discovery.  The webinar sese experts and leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug… Read More

Webinar date:
Sponsored by Emulate
#News

#Drug discovery

Webinar: Advancing high-throughput cardiac screening with physiologically relevant 3D iPSC-based models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in high-throughput applications… Read More

#Webinars

#Artificial intelligence (AI) #Drug discovery #eBook #Imaging

eBook: The importance of imaging in drug discovery

Various imaging modalities are used throughout the process of drug discovery and development, both in the preclinical and clinical phases. According to analysts, Valuates, the global preclinical imaging market was valued at $1887.9 million in 2023 and is anticipated to reach $3021.2 million by 2030. Read More

#News

#Cardioprotection #Drug discovery #Drug safety #Drug toxicity #Whitepaper

Whitepaper: Transforming cardiac safety testing

Discover how VOLTA Scanner is transforming cardiac safety testing. This Whitepaper from Lumencor describes an optophysiology instrument, supporting stable, fast, high-resolution toxicity testing and drug development. Download to learn how: VOLTA detects early-after-depolarisations (EADs), and predicts QT/QRS risk Optogenetic pacing improves assay precision Automated, HPT optophysiological screening streamlines… Read More

#News

#Cardioprotection #Drug discovery #Drug safety #Drug toxicity

VOLTA Scanner illuminates cardiac safety testing

VOLTA Scanner is transforming cardiac safety testing. This whitepaper describes an optophysiology instrument, supporting stable, fast, high-resolution toxicity testing and drug development. Download to learn how: VOLTA detects early-after-depolarisations (EADs), and predicts QT/QRS risk Optogenetic pacing improves assay precision Automated, HPT optophysiological screening streamlines decisions… Read More

#Resources